CDEK
← All organizations

Acetylon Pharmaceuticals Incorporated

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 1, 2014

Last known activity

May 1, 2016

Acquired by Celgene → Bristol-Myers Squibb on Dec 2, 2016

Timeline

2000s

  1. Jan 1, 2008

    Acetylon Pharmaceuticals Incorporated— Founded

2010s

  1. Dec 2, 2016

    Celgene— Acquired By

  2. Jan 3, 2019

    Bristol-Myers Squibb— Now

Drugs by trial phase (5 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

Details

Founded
Boston, MA, US Jan 1, 2008
Last known activity
May 1, 2016